Section

General

No CPD Points

Course Summary

Subretinal implants – Robert MacLaren and Deborah Lea (Part 1 – 11:56; Part 2 – 10:54)

This two-part interview details developments being made in the field of subretinal implant technology. Retinal implants aim to partially restore useful vision to people who have lost theirs due to degenerative eye conditions such as retinitis pigmentosa or macular degeneration. Deborah Lea talks to Robert MacLaren about the clinical trials he is running of the subretinal implants developed by the German company Retina Implant AG.

First published in DOCET OQ81 (2012).

    Open all

    Instructions: Clicking on the section name will show / hide the section.

    View only 'Topic 1'

    To provide listeners with:

    • An outline of the developments being made in the field of retinal implant technology by the German company Retina Implant AG
    • An outline of the prevalence of macular disease and retinitis pigmentosa
    • An understanding of the trials currently being run on new subretinal implants
    • An outline of how retinal implants – both epiretinal and subretinal – are showing promise in combating these diseases
    • An understanding of how patients with macular degeneration may benefit from subretinal implants in the future

      View only 'Topic 2'
      View only 'Topic 3'
      View only 'Topic 4'

      References:

      • Zrenner E, Bartz-Schmidt KU, Benav H et al. (2011) Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci. May 22;278 (1711):1489-97

        View only 'Topic 5'

        Please give your feedback on this course. Please click on the link below to launch the evaluation form.